Marrone Bio Innovations To Open Bangor, Michigan, Manufacturing Facility
08/06/2012
MBI officials said its new facility will provide the necessary capacity to advance its growing pipeline of natural pest management products, or biopesticides, for the agriculture and water treatment markets.
"This marks a significant milestone for MBI," said CEO Pam Marrone. "Having our own manufacturing facility will be a tremendous asset to us, both in terms of cost effectiveness and quality assurance for our existing products and as we seek to rapidly advance our pipeline of new products from development to commercialization."
The site is former a biodiesel production facility, which was most recently used for production of glycerin. MBI will begin retrofitting and repurposing the site for fermentation this month, and intends to initiate manufacturing in early 2013. In addition to the manufacturing plant, the site includes offices and a laboratory. The facility will initially employ up to 30 people, but MBI intends to increase employment to 50 workers over the next few years.
MBI anticipates manufacturing Grandevo, a broad-spectrum bioinsecticide for controlling insects and mites, as well as Zequanox, the industry's first naturally derived product for controlling invasive zebra and quagga mussels at the new facility.
In addition to Grandevo and Zequanox, MBI has several early stage products that if developed will ultimately be manufactured in Bangor. Those include an EPA-approved bioherbicide and an additional insecticide, currently undergoing EPA review. Additionally, the company has several nematicide, herbicide, fungicide, algaecide and plant health product candidates under development that could be produced at the site.
Financial details about the firm's investment were not disclosed; however, MBI noted its executive team has extensive experience acquiring, developing and operating fermentation facilities.
While information on incentives offered the firm was not immediately available, Don Glidewell, MBI chief financial officer said. "With this acquisition we lay the cornerstone of our manufacturing strategy. We anticipate that operating our own site will provide MBI additional capacity and flexibility to efficiently manufacture new products. At the same time, MBI will maintain certain strategic contract manufacturing partnerships, which we expect will mitigate the risk of single source of production."
Project Announcements
Daisy Brand Plans Boone, Iowa, Production Operations
04/22/2024
Canfor Expands Fulton, Alabama, Production Operations
04/22/2024
Tucker Door & Trim Plans Henrico County, Virginia, Operations
04/19/2024
Zekelman Industries Expands Blytheville, Arkansas, Operations
04/19/2024
Fibrebond Corporation Expands Webster Parish, Louisiana, Operations
04/19/2024
Master Steel Expands Hardeeville, South Carolina, Operations
04/19/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024